The global healthcare business process outsourcing (BPO) market is witnessing significant growth, due to technological advancements in healthcare IT sector and increasing demand for reducing healthcare costs. The tenth revision of International Statistical Classification of Diseases and Health Related Problems (ICD-10), emergence of biologics and massive unexplored healthcare BPO market in the emerging economies are creating ample opportunities for the growth of the global healthcare BPO market. Healthcare reforms across the globe and adoption of healthcare BPO by major pharmaceuticals, biopharmaceuticals and biotechnology companies are supporting the demand of cost effective and improved healthcare system.
Healthcare BPO is the practice of outsourcing business operations by healthcare providers, payers and organizations. Healthcare BPO has several advantages, such as availability of skilled workforce at low cost, reduction in training and administrative costs, and high profitability for healthcare organizations, payers, and providers. In addition, healthcare BPO also improves the quality of patient care, while reducing the investment required for infrastructure.
The global healthcare BPO market is segmented into pharmaceuticals outsourcing, providers outsourcing, and payers outsourcing. The pharmaceutical outsourcing segment leads the global healthcare BPO market. The pharmaceuticals outsourcing segment can be further categorized as contract manufacturing organizations (CMO), contract research organizations (CRO) and non-clinical services. The healthcare providers outsourcing segment includes medical transcription, medical billing, medical coding, and finance and accounts. The healthcare payers outsourcing segment includes customer care and member services, HR services, claims processing, and finance and accounts.
Some of the factors driving the growth of the global healthcare BPO market are increasing healthcare costs, advancement in the healthcare IT technology, lack of skilled professionals and increasing demand for improved healthcare. In addition, the high cost associated with R&D and manufacturing of drugs, and reduced productivity is compelling the major pharmaceuticals companies to outsource their business processes. However, data security and privacy concerns, unforeseen costs, and difference in the regulatory processes within different countries are restraining the growth of the global healthcare BPO market.
Geographically, the global healthcare BPO market is categorized as outsourcing source geographies, and destination source geographies. Based on the outsourcing source geographies, the market is segmented into the U.S., Europe and Rest of the World. The U.S. dominates the global healthcare BPO market, among all the outsourcing source geographies. The reasons for the dominance of the U.S. in the market are the increasing demand to reduce healthcare costs, and high cost associated with the R&D and manufacturing of drugs in the region. In addition, the legislative reform of Patient Protection and Affordable Care Act in the U.S. is also driving the healthcare business process outsourcing market in the U.S. for affordable and improved healthcare. Europe is the fastest growing outsourcing source geography, in the global healthcare BPO market. The major reason behind fastest growth of Europe as outsourcing source geography is due to the increasing demand for improved and cost-effective healthcare in the region.
On the basis of outsourcing destination geographies, the global healthcare BPO market comprises the U.S., India, Philippines, Europe, Latin America and Rest of the World. Again, the U.S. leads the global healthcare BPO market as outsourcing destination geography. Philippines is the fastest growing outsourcing destination geography in the global healthcare BPO market, due to availability of skilled workforce at low cost and advancements in healthcare IT technology.
Some of the major players operating in the global healthcare BPO market are Accenture, Tata Consultancy Services (a part of Tata Group), Genpact, Boehringer Ingelheim GmbH, Cognizant, Charles River Laboratories International Inc., Covance Inc., Infosys Limited, Lonza Group Ltd. and Quintiles Inc.
Report Coverage
- Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
- Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
- Uncovers potential demands in the market
- Porter analysis identifies competitive forces within the market
- Provides information on the historical and current market size and the future potential of the market
- Provides sizes of key regional markets using yardsticks of segments
- Highlights the competitive scenario of the market and major competitors
- Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics. Profiles provide better understanding of competition as well as the demands of the market.
